Fengjun Cao

820 total citations
23 papers, 589 citations indexed

About

Fengjun Cao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fengjun Cao has authored 23 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Fengjun Cao's work include Cancer-related Molecular Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Fengjun Cao is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Fengjun Cao collaborates with scholars based in China, Hong Kong and Germany. Fengjun Cao's co-authors include Xuanbin Wang, Xiaojun Cai, Yibin Feng, Xiongjie Yu, Chen Li, Minglun Li, Longchao Xiang, Hongliang Li, Nian Yang and Jingxuan Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Food and Chemical Toxicology.

In The Last Decade

Fengjun Cao

23 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengjun Cao China	16	355	136	127	74	70	23	589
Hsi‐Hsien Hsu Taiwan	12	309 0.9×	145 1.1×	177 1.4×	53 0.7×	53 0.8×	31	646
Amit Kumar Verma India	15	307 0.9×	133 1.0×	104 0.8×	40 0.5×	65 0.9×	41	639
Kangdong Liu China	15	405 1.1×	101 0.7×	121 1.0×	67 0.9×	64 0.9×	44	644
Ji Young Sul South Korea	12	370 1.0×	124 0.9×	106 0.8×	55 0.7×	38 0.5×	20	592
Chengtao Sun China	17	363 1.0×	125 0.9×	114 0.9×	54 0.7×	82 1.2×	43	723
Jiao Li China	16	392 1.1×	132 1.0×	107 0.8×	30 0.4×	68 1.0×	31	686
Weili Min China	17	299 0.8×	110 0.8×	132 1.0×	41 0.6×	92 1.3×	26	591
Fangtian Fan China	18	414 1.2×	192 1.4×	142 1.1×	51 0.7×	115 1.6×	44	760
Nan Yao China	14	344 1.0×	159 1.2×	122 1.0×	63 0.9×	77 1.1×	31	579

Countries citing papers authored by Fengjun Cao

Since Specialization

Citations

This map shows the geographic impact of Fengjun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjun Cao more than expected).

Fields of papers citing papers by Fengjun Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengjun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjun Cao. The network helps show where Fengjun Cao may publish in the future.

Co-authorship network of co-authors of Fengjun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengjun Cao. A scholar is included among the top collaborators of Fengjun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengjun Cao. Fengjun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Fengjun, et al.. (2023). BDH2 promotes apoptosis and autophagy of lung adenocarcinoma cells via Akt/mTOR pathway. General Physiology and Biophysics. 41(2). 115–122. 5 indexed citations

Wang, Yu, Kai Li, Hao Liu, et al.. (2022). Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma. World Journal of Surgical Oncology. 20(1). 236–236. 1 indexed citations

Shi, Run, Xin Wang, Yang Wu, et al.. (2022). APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases. Theranostics. 12(9). 4181–4199. 34 indexed citations

Wang, Dongpeng, Xiongjie Yu, Fengjun Cao, et al.. (2021). Pharmacokinetics of Anthraquinones from Medicinal Plants. Frontiers in Pharmacology. 12. 638993–638993. 84 indexed citations

Zhang, Li, Wei Zhang, Ying Song, et al.. (2021). Circ_0008673 regulates breast cancer malignancy by miR-153-3p/CFL2 axis. Archives of Gynecology and Obstetrics. 305(1). 223–232. 17 indexed citations

Li, Xiaohua, et al.. (2021). Nanofibrous bicomponent scaffolds for the dual delivery of NGF and GDNF: controlled release of growth factors and their biological effects. Journal of Materials Science Materials in Medicine. 32(1). 9–9. 16 indexed citations

Liu, Chaoyu, Yuancai Xie, Xiaohua Li, et al.. (2020). Folic Acid/Peptides Modified PLGA–PEI–PEG Polymeric Vectors as Efficient Gene Delivery Vehicles: Synthesis, Characterization and Their Biological Performance. Molecular Biotechnology. 63(1). 63–79. 25 indexed citations

Cao, Fengjun, et al.. (2019). Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer. Journal of Cancer. 10(2). 416–417. 5 indexed citations

Yang, Nian, Chen Li, Hongliang Li, et al.. (2019). Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology. 10. 709–709. 41 indexed citations

10.

Ding, Yan, Yong Li, Minglun Li, et al.. (2019). Chinese Medicines for Preventing and Treating Radiation-Induced Pulmonary Injury: Still a Long Way to Go. Frontiers in Pharmacology. 10. 927–927. 4 indexed citations

11.

Li, Hongliang, Longchao Xiang, Nian Yang, et al.. (2018). Zhiheshouwu ethanol extract induces intrinsic apoptosis and reduces unsaturated fatty acids via SREBP1 pathway in hepatocellular carcinoma cells. Food and Chemical Toxicology. 119. 169–175. 19 indexed citations

12.

Cao, Fengjun, Mingxing Li, Pindong Li, et al.. (2018). Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer. Redox Biology. 20. 451–457. 19 indexed citations

13.

Li, Fang, Xuanbin Wang, Chen Li, et al.. (2018). Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry. 49(3). 837–847. 45 indexed citations

14.

Lin, Tian, Yuandong Yu, Fang Li, et al.. (2017). Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer. Biochemical and Biophysical Research Communications. 491(1). 104–111. 32 indexed citations

15.

Yu, Yanhui, Fengjun Cao, Xiaolei Yu, et al.. (2017). The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis. Clinical & Translational Oncology. 19(8). 1045–1054. 27 indexed citations

16.

Dong, Xiao‐Li, Zhen-Nan Ye, Fengjun Cao, et al.. (2017). Maslinic acid promotes autophagy by disrupting the interaction between Bcl2 and Beclin1 in rat pheochromocytoma PC12 cells. Oncotarget. 8(43). 74527–74538. 15 indexed citations

17.

Yu, Xiongjie, et al.. (2016). Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects. OncoTargets and Therapy. 9. 2049–2049. 5 indexed citations

18.

Xiang, Longchao, et al.. (2016). Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients. Oncotarget. 8(3). 5382–5391. 21 indexed citations

19.

Wang, Xuanbin, Ning Wang, Ming Liu, et al.. (2016). Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. International Journal of Molecular Sciences. 17(4). 577–577. 34 indexed citations

20.

Yu, Xiongjie, Ping Chen, Dongfeng Pan, et al.. (2016). Metformin therapy associated with survival benefit in lung cancer patients with diabetes. Oncotarget. 7(23). 35437–35445. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact